Viral Hepatitis Program
The Viral Hepatitis Program offers the most advanced clinical therapies to patients with hepatitis B and C, including trials of new long-acting interferons given in combination with other anti-viral treatments. The program specializes in treating patients who are co-infected with HIV and hepatitis C, and in using new therapies to prevent progression of liver disease.
